{"product_id":"global-diagnostic-imaging-partnering-terms-and-agreements-2016-to-2023","title":"Global Diagnostic Imaging Partnering Terms and Agreements 2016 to 2023","description":"\u003cp\u003eGlobal Diagnostic Imaging Partnering Terms and Agreements 2016 to 2023\u003cbr\u003e\nThe Global Diagnostic Imaging Partnering Terms and Agreements 2016 to 2023 report provides comprehensive understanding and unprecedented access to the diagnostic imaging partnering agreements entered into by the worlds leading healthcare companies.\u003c\/p\u003e\n\n\u003cp\u003eThe report provides a detailed understanding and analysis of how and why companies enter diagnostic imaging partnering deals.  This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering:\u003c\/p\u003e\n\n\u003cp\u003eImaging\u003cbr\u003e\nCT\u003cbr\u003e\nEndoscope\u003cbr\u003e\nMolecular and nuclear\u003cbr\u003e\nPET\u003cbr\u003e\nSPECT\u003cbr\u003e\nMRI\u003cbr\u003e\nUltrasound\u003cbr\u003e\nX ray\u003cbr\u003e\nAngiography\u003cbr\u003e\nFluoroscopy\u003cbr\u003e\nMammography\u003c\/p\u003e\n\n\n\u003cp\u003eThis report provides an overview of diagnostic imaging dealmaking, the common clauses, rights and options in the partnering agreement, and also a comprehensive review of deals signed in since 2016.\u003c\/p\u003e\n\n\u003cp\u003eThis report provides a comprehensive and detailed review of all diagnostic imaging deals announced since 2016. The comprehensive agreements chapter is organized by company A-Z, stage of development at signing, deal type, and therapy focus. Each deal title links via Weblink to an online version of the actual deal at Current Agreements (www.currentagreements.com) deals and alliances database, providing easy access to each deal on demand. Where available, the full deal contract document is also provided and indicated by a document symbol.\u003c\/p\u003e\n\n\u003cp\u003eContract documents provide unsurpassed access to the detail of a deal normally announced in brief summary through a press release. Detailed analysis of a contract allow better understanding of the terms agreed between the parties, and importantly the basis under which monies and licensing rights are exchanged.\u003c\/p\u003e\n\n\u003cp\u003eThe initial chapters of this report provide an orientation of diagnostic imaging dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in diagnostic imaging dealmaking since 2016, including details of average headline, upfront, milestone and royalty terms.\u003c\/p\u003e\n\n\u003cp\u003eChapter 3 provides a review of the leading diagnostic imaging deals since 2016. Deals are listed by headline value, signed by big pharma, most active diagnostic imaging dealmaking companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.\u003c\/p\u003e\n\n\u003cp\u003eChapter 4 provides a comprehensive listing of the top 25 most active companies in diagnostic imaging dealmaking with a brief summary followed by a comprehensive listing of diagnostic imaging deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.\u003c\/p\u003e\n\n\u003cp\u003eChapter 5 provides a comprehensive and detailed review of diagnostic imaging partnering deals signed and announced since Jan 2016, where a contract document is available in the public domain.\u003c\/p\u003e\n\n\u003cp\u003eChapter 6 provides a comprehensive and detailed review of diagnostic imaging partnering deals signed and announced since Jan 2016. The chapter is organized by specific diagnostic imaging technology type in focus.\u003c\/p\u003e\n\n\u003cp\u003eIn addition, a comprehensive appendix is provided organized by diagnostic imaging partnering company A-Z, deal type definitions and diagnostic imaging partnering agreements example.\u003c\/p\u003e\n\n\u003cp\u003eThe report also includes numerous tables and figures that illustrate the trends and activities in diagnostic imaging partnering and dealmaking since 2016.\u003c\/p\u003e\n\n\u003cp\u003eIn conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of diagnostic imaging technologies and products.\u003c\/p\u003e\n\n\u003cp\u003eKey benefits\u003c\/p\u003e\n\n\u003cp\u003eGlobal Diagnostic Imaging Partnering Terms and Agreements provides the reader with the following key benefits:\u003c\/p\u003e\n\n\u003cp\u003eIn-depth understanding of diagnostic deal trends since 2016\u003cbr\u003e\nComprehensive access to over 900 actual diagnostic imaging deals entered into by the world’s biopharma companies\u003cbr\u003e\nDetailed access to actual diagnostic contracts enter into by the leading biopharma companies\u003cbr\u003e\nInsight into the terms included in a diagnostic agreement, together with real world clause examples\u003cbr\u003e\nUnderstand the key deal terms companies have agreed in previous deals\u003cbr\u003e\nUndertake due diligence to assess suitability of your proposed deal terms for partner companies\u003c\/p\u003e\n\n\n\u003cp\u003eReport scope\u003c\/p\u003e\n\n\u003cp\u003eGlobal Diagnostic Imaging Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding of the diagnostic imaging trends and structure of deals entered into by leading companies worldwide.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Diagnostic Imaging Partnering Terms and Agreements includes:\u003c\/p\u003e\n\n\u003cp\u003eTrends in diagnostic imaging dealmaking in the biopharma industry since 2016\u003cbr\u003e\nAccess to over 900 diagnostic imaging contract documents\u003cbr\u003e\nThe leading diagnostic imaging deals by value since 2016\u003cbr\u003e\nMost active diagnostic imaging  dealmakers since 2016\u003cbr\u003e\nThe leading diagnostic imaging partnering resources\u003c\/p\u003e\n\n\n\u003cp\u003eIn Global Diagnostic Imaging Partnering Terms and Agreements, the available contracts are listed by:\u003c\/p\u003e\n\n\u003cp\u003eHeadline value\u003cbr\u003e\nStage of development at signing\u003cbr\u003e\nDeal component type\u003cbr\u003e\nSpecific therapy target\u003cbr\u003e\nSpecific technology target\u003c\/p\u003e\n\n\u003cp\u003eEach deal title links to online deal records of actual diagnostic imaging partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.\u003c\/p\u003e\n\n\n\u003cp\u003eThe Global Diagnostic Imaging Partnering Terms and Agreements report provides comprehensive access to available contract documents for over 900 diagnostic imaging deals. Analyzing actual contract agreements allows assessment of the following:\u003c\/p\u003e\n\n\u003cp\u003eWhat are the precise diagnostic rights granted or optioned?\u003cbr\u003e\nWhat is actually granted by the agreement to the partner company?\u003cbr\u003e\nWhat exclusivity is granted?\u003cbr\u003e\nWhat is the payment structure for the deal?\u003cbr\u003e\nHow are sales and payments audited?\u003cbr\u003e\nWhat is the deal term?\u003cbr\u003e\nHow are the key terms of the agreement defined?\u003cbr\u003e\nHow are IPRs handled and owned?\u003cbr\u003e\nWho is responsible for commercialization?\u003cbr\u003e\nWho is responsible for development, supply, and manufacture?\u003cbr\u003e\nHow is confidentiality and publication managed?\u003cbr\u003e\nHow are disputes to be resolved?\u003cbr\u003e\nUnder what conditions can the deal be terminated?\u003cbr\u003e\nWhat happens when there is a change of ownership?\u003cbr\u003e\nWhat sublicensing and subcontracting provisions have been agreed?\u003cbr\u003e\nWhich boilerplate clauses does the company insist upon?\u003cbr\u003e\nWhich boilerplate clauses appear to differ from partner to partner or deal type to deal type?\u003cbr\u003e\nWhich jurisdiction does the company insist upon for agreement law?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"June, 2023 \/ 500 Pages \/ MCW16236941","offer_id":47652318183730,"sku":null,"price":4794.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-diagnostic-imaging-partnering-terms-and-agreements-2016-to-2023","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}